Michael has ten years experience in scientific research, from nucleic acid chemistry to protein expression and crystallography, resulting in twelve published papers. Alongside a key role in protein engineering and technology development, he ensures Nuclera's scientific strategy serves its business strategy. Michael holds a BSc in Chemistry from the Georgia Institute of Technology, and a PhD in Chemistry from the University of Cambridge and the National Institutes of Health.